NK-374186A3

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameNK-374186A3
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionT lymphocytes inhibitors
TargetsUpdating
Therapy Area/IndicationsImmune System DiseasesOvarian Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNippon Kayaku Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNippon Kayaku Co Ltd
Active IndicationsN/A
Inactive IndicationsImmune System DiseasesOvarian Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A